THE EFFECT LAB ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.3% 5.2% 4.6% 4.0% 3.1%  
Credit score (0-100)  43 43 44 49 56  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  938 416 1,122 194 322  
EBITDA  152 202 1,000 69.5 207  
EBIT  55.3 39.9 856 -55.0 128  
Pre-tax profit (PTP)  18.3 9.1 839.4 -67.4 108.7  
Net earnings  10.1 7.0 776.1 -61.8 101.7  
Pre-tax profit without non-rec. items  18.3 9.1 839 -67.4 109  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  8.2 2.4 0.0 0.0 0.0  
Shareholders equity total  83.8 -9.7 766 705 806  
Interest-bearing liabilities  467 575 44.6 13.2 13.2  
Balance sheet total (assets)  832 774 994 1,443 1,503  

Net Debt  465 573 42.6 -394 -660  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  938 416 1,122 194 322  
Gross profit growth  -33.6% -55.6% 169.6% -82.7% 66.4%  
Employees  0 0 0 0 0  
Employee growth %  -100.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  832 774 994 1,443 1,503  
Balance sheet change%  -50.6% -7.0% 28.4% 45.2% 4.1%  
Added value  152.2 201.9 1,000.3 89.3 207.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  722 -296 -389 -249 -160  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 -1.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5.9% 9.6% 76.3% -28.4% 39.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  4.7% 4.9% 96.3% -4.5% 8.8%  
ROI %  6.8% 7.1% 123.5% -7.2% 16.9%  
ROE %  4.0% 1.6% 100.8% -8.4% 13.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  10.1% -1.2% 77.1% 48.8% 53.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  305.7% 283.7% 4.3% -567.6% -318.2%  
Gearing %  557.4% -5,909.2% 5.8% 1.9% 1.6%  
Net interest  0 0 0 0 0  
Financing costs %  6.6% 5.9% 5.4% 42.9% 159.8%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.5 0.4 3.1 11.1 20.0  
Current Ratio  0.5 0.4 3.1 11.1 20.0  
Cash and cash equivalent  2.0 2.0 2.0 407.5 672.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -380.4 -443.6 476.8 548.8 705.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0